Biotech Updates

Dow and Chromatin Sign Research, License Agreement

November 13, 2009

Dow AgroSciences announced that it has entered in to an agreement with Chicago-based Chromatin Inc. in hopes of developing the next generation traits in corn, soybeans and canola. The agreement gives Dow access to Chromatin's Mini-Chromosome technology and establishes an exclusive research and license agreement to combine EXZACT Precision Technology with Mini-Chromosomes. EXZACT, Dow's proprietary toolkit for targeted genetic modification, allows engineering of multi-gene stacks. Chromatin's Mini-Chromosome technology, on the other hand, allows delivery of autonomous plant chromosomes that carry complex multi-gene traits. The companies said that combining these technologies will "get products to the market faster and at a lower cost." Financial details of the agreement were not disclosed.

For more information, read